Key Dates

Related Announcements

PAR-18-418 - NIDDK Mentored Research Scientist Development Award (K01-Clinical Trials Required)

PAR-18-419 - NIDDK Mentored Research Scientist Development Award (K01 No Independent Clinical Trials)

PA-20-190 - Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)

PA-20-176 - Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)

NOT-DK-21-019 -NIDDK Notice of Continuation of Temporary Extension of Eligibility for the NIH Mentored Research Scientist Development Award (K01) Award During the COVID-19 Pandemic

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

Under normal circumstances, individuals applying to the NIH Mentored Research Scientist Development Award (K01) with a project within the mission interests of the NIDDK must have no more than 7 years of post-doctoral research experience. The purpose of this notice is to inform the extramural community that due to disruptions caused by the COVID-19 pandemic, the NIDDK will be providing up to a two-receipt cycle extension (roughly eight additional months) of eligibility for prospective applicants meeting the requirements for submission of a K01 application from the time period covered by the June/July 2020 due dates through the February/March 2021 due dates.

Implementation

The two-receipt cycle extension in eligibility under this Notice applies only to applicants for a K01 award under one of the following Funding Opportunity Announcements: PAR-18-419: NIDDK Mentored Research Scientist Development Award (K01-No Independent Clinical Trials), PAR-18-418: NIDDK Mentored Research Scientist Development Award (K01-Clinical Trials Required), PA-20-176: Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required), and PA-20-190: Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed).

For eligible applicants submitting new or resubmission applications, the two-receipt cycle extension will be automatically accepted by the NIH; no additional documentation is required.

To aid potential applicants in determining whether they are eligible for the extension, the following examples are provided:

Example 1: For individuals whose eligibility ended with the June/July 12, 2020 due dates, the temporary extension would allow them to apply for the K99/R00 in October/November 2020 or February/March 2021.

Example 2: For individuals whose eligibility ended with October/November 12, 2020 due dates, the temporary extension would allow them to apply in February/March 2021 or June/July 2021.

Example 3: For individuals whose eligibility would normally end with February/March 12, 2021 due dates, the temporary extension would allow them to apply in June/July 2021 or October/November 2021.

This policy may be subject to future updates.

Inquiries

Please direct all inquiries to:

Tracy L. Rankin, Ph.D., M.P.H.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 594-4748
Email: [email protected]